Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 886-888

  Bunnapradist, S ^a   Hong, A ^a   Lee, B ^a   Takemoto, S K ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Health Benchmarks Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; DACLIZUMAB; THYMOCYTE ANTIBODY;

CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; GRAFT REJECTION; HAPLOTYPE; HLA MATCHING; HUMAN; KIDNEY TRANSPLANTATION; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 17844368380     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.084     Document Type: Conference Paper

References (6)

1. A.O. Gaber, M.R. First, R.J. Tesi Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation Transplantation 66 1998 29
2. F. Vincenti, R. Kirkman, S. Light Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group N Engl J Med 338 1998 161
3. S. Bunnapradist, A. Daswani, S.K. Takemoto Multivariate analyses of antibody induction therapy Clin Transpl 2003 405
4. S.K. Takemoto, Y.W. Cho, D.W. Gjertson Transplant risks Clin Transplants 1999 325
5. S.K. Takemoto, P.I. Terasaki, D.W. Gjertson Twelve years' experience with national sharing of HLA-matched deceased kidneys for transplantation N Engl J Med 343 2000 1078
6. Y.C. Zhou, J.M. Cecka The UNOS Scientific Renal Transplant Registry Clin Transplants 1993 1